Current Systemic Therapy Options for Head and Neck Cancers
作者： Mehmet Ali Nahit Sendur , Sercan Aksoy
DOI: 10.1007/978-3-319-10413-3_2
关键词:
摘要: Head and neck cancers refer to heterogeneous group of tumors extending from the lips lower esophagus. Squamous cell cancer is most common histologic variant, accounting approximately 90–95 % head cancers. The incidence still continues increase worldwide with half million cases per year [1]. In United States, it estimated about 55.070 new will occur in 2014 which account for up 3 [2]. 2014, that 12.000 deaths States. Europe, 139.000 [3]. 1-year survival rate was 72 %, whereas 5-year only 42 adults
springer.com
sci-hub.st 参考文章(48)
信和 不破, 達也 中村, What's going on 頭頸部癌 Defining risk levels in locally advanced head and neck cancers: A comparative analysis of concurrent postoperative radiation plus chemotherapy trials of the EORTC (#22931) and RTOG (#9501). Bernier J, Cooper JS, Pajak TF, van Glabbeke M, Bourhis J, Forastiere A, Ozsahin EM, Jacobs JR, Jassem J, Ang KK, Lefebvre JL. Head Neck. 2005; 27: 843-50. PMID: 16161069.--局所進行頭頸部癌に対する術後化学放射線療法の有効性を示したEORTC(#22931)とRTOG(#9501)の結果を分析し、化学療法併用が寄与する症例群を明らかにした論文 Mebio oncology. ,vol. 3, pp. 123- 125 ,(2006)
A A Forastiere, B Metch, D E Schuller, J F Ensley, L F Hutchins, P Triozzi, J A Kish, S McClure, E VonFeldt, S K Williamson, Randomized comparison of cisplatin plus fluorouracil and carboplatin plus fluorouracil versus methotrexate in advanced squamous-cell carcinoma of the head and neck: a Southwest Oncology Group study. Journal of Clinical Oncology. ,vol. 10, pp. 1245- 1251 ,(1992) , 10.1200/JCO.1992.10.8.1245
David J. Adelstein, Pierre Lavertu, Jerrold P. Saxton, Michelle Secic, Benjamin G. Wood, John R. Wanamaker, Isaac Eliachar, Marshall Strome, Marjorie A. Larto, Mature results of a phase III randomized trial comparing concurrent chemoradiotherapy with radiation therapy alone in patients with stage III and IV squamous cell carcinoma of the head and neck. Cancer. ,vol. 88, pp. 876- 883 ,(2000) , 10.1002/(SICI)1097-0142(20000215)88:4<876::AID-CNCR19>3.0.CO;2-Y
J.P Pignon, J Bourhis, C Domenge, L Designe, Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. MACH-NC Collaborative Group. Meta analysis of chemotherapy on head and neck cancer Cancer Radiotherapie. ,vol. 5, pp. 201- 202 ,(2001) , 10.1016/S1278-3218(00)00073-1
Jean Bourhis, Aurélie Le Maître, Bertrand Baujat, Hélène Audry, Jean-Pierre Pignon, Individual patients' data meta-analyses in head and neck cancer Current Opinion in Oncology. ,vol. 19, pp. 188- 194 ,(2007) , 10.1097/CCO.0B013E3280F01010
Jan B. Vermorken, Eva Remenar, Carla van Herpen, Thierry Gorlia, Ricard Mesia, Marian Degardin, John S. Stewart, Svetislav Jelic, Jan Betka, Joachim H. Preiss, Danielle van den Weyngaert, Ahmad Awada, Didier Cupissol, Heinz R. Kienzer, Augustin Rey, Isabelle Desaunois, Jacques Bernier, Jean-Louis Lefebvre, Cisplatin, fluorouracil, and docetaxel in unresectable head and neck cancer. The New England Journal of Medicine. ,vol. 357, pp. 1695- 1704 ,(2007) , 10.1056/NEJMOA071028
Marco Merlano, Vito Vitale, Riccardo Rosso, Marco Benasso, Renzo Corvò, Monica Cavallari, Giuseppe Sanguineti, Almalina Bacigalupo, Fausto Badellino, Giovanni Margarino, Fulvio Brema, Gisella Pastorino, Corrado Marziano, Andrea Grimaldi, Felice Scasso, Giuseppe Sperati, Eugenio Pallestrini, Giacomo Garaventa, Emilio Accomando, Giovanni Cordone, Giuseppe Comella, Antonio Daponte, Alessandra Rubagotti, Paolo Bruzzi, Leonardo Santi, Treatment of Advanced Squamous-Cell Carcinoma of the Head and Neck with Alternating Chemotherapy and Radiotherapy New England Journal of Medicine. ,vol. 327, pp. 1115- 1121 ,(1992) , 10.1056/NEJM199210153271602
Jay S. Cooper, Qiang Zhang, Thomas F. Pajak, Arlene A. Forastiere, John Jacobs, Scott B. Saxman, Julie A. Kish, Harold E. Kim, Anthony J. Cmelak, Marvin Rotman, Robert Lustig, John F. Ensley, Wade Thorstad, Christopher J. Schultz, Sue S. Yom, K. Kian Ang, Long-term follow-up of the RTOG 9501/intergroup phase III trial: postoperative concurrent radiation therapy and chemotherapy in high-risk squamous cell carcinoma of the head and neck. International Journal of Radiation Oncology Biology Physics. ,vol. 84, pp. 1198- 1205 ,(2012) , 10.1016/J.IJROBP.2012.05.008
Sandra Schmitz, Kie Kian Ang, Jan Vermorken, Robert Haddad, Carlos Suarez, Gregory T. Wolf, Marc Hamoir, Jean-Pascal Machiels, Targeted therapies for squamous cell carcinoma of the head and neck: current knowledge and future directions. Cancer Treatment Reviews. ,vol. 40, pp. 390- 404 ,(2014) , 10.1016/J.CTRV.2013.09.007
Katharine A. R. Price, Ezra E. Cohen, Current treatment options for metastatic head and neck cancer. Current Treatment Options in Oncology. ,vol. 13, pp. 35- 46 ,(2012) , 10.1007/S11864-011-0176-Y